Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20035309HPVENSG00000135250.17protein_codingSRPK2NoNo6733P78362
TVIS44019772HTLV-1ENSG00000135250.17protein_codingSRPK2NoNo6733P78362
TVIS44013548HTLV-1ENSG00000135250.17protein_codingSRPK2NoNo6733P78362
TVIS44016698HTLV-1ENSG00000135250.17protein_codingSRPK2NoNo6733P78362
TVIS44039733HTLV-1ENSG00000135250.17protein_codingSRPK2NoNo6733P78362
TVIS44050578HTLV-1ENSG00000135250.17protein_codingSRPK2NoNo6733P78362
TVIS44050579HTLV-1ENSG00000135250.17protein_codingSRPK2NoNo6733P78362
TVIS44045757HTLV-1ENSG00000135250.17protein_codingSRPK2NoNo6733P78362
TCGA Plot Options
Drug Information
GeneSRPK2
DrugBank IDDB00173
Drug NameAdenine
Target IDBE0004323
UniProt IDP78362
Regulation Type
PubMed IDs10592235
CitationsBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
GroupsApproved; Nutraceutical
Direct Classification6-aminopurines
SMILESNC1=C2NC=NC2=NC=N1
PathwaysGout or Kelley-Seegmiller Syndrome; Purine Metabolism; Lesch-Nyhan Syndrome (LNS); Myoadenylate Deaminase Deficiency; Molybdenum Cofactor Deficiency; Adenine Phosphoribosyltransferase Deficiency (APRT); Mercaptopurine Action Pathway; Xanthinuria Type I; Azathioprine Action Pathway; AICA-Ribosiduria; Thioguanine Action Pathway; Mitochondrial DNA Depletion Syndrome; Adenosine Deaminase Deficiency; Xanthine Dehydrogenase Deficiency (Xanthinuria); Purine Nucleoside Phosphorylase Deficiency; Adenylosuccinate Lyase Deficiency; Xanthinuria Type II
PharmGKBPA448048
ChEMBLCHEMBL226345